The Quality of Pharmacoeconomic Evaluations of Age-Related Macular Degeneration Therapeutics: A Systematic Review and Quantitative Appraisal of the Evidence

British Journal of Ophthalmology - United Kingdom
doi 10.1136/bjo.2009.170282
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Appraising the Quality of Systematic Reviews for Age-Related Macular Degeneration Interventions

JAMA Ophthalmology
Ophthalmology
2018English

Conbercept for Patients With Age-Related Macular Degeneration: A Systematic Review

BMC Ophthalmology
MedicineOphthalmology
2018English

Homocysteine and Risk of Age-Related Macular Degeneration: A Systematic Review and Meta-Analysis

Acta Ophthalmologica
MedicineOphthalmology
2016English

Age-Related Macular Degeneration and the Incidence of Cardiovascular Disease: A Systematic Review and Meta-Analysis

PLoS ONE
Multidisciplinary
2014English

A Systematic Review on the Quality, Validity and Usefulness of Current Cost-Effectiveness Studies for Treatments of Neovascular Age-Related Macular Degeneration

Acta Ophthalmologica
MedicineOphthalmology
2018English

Age-Related Macular Degeneration and Quality of Life in Latinos

JAMA Ophthalmology
Ophthalmology
2016English

Age-Related Macular Degeneration—Review and Current Concepts

US Ophthalmic Review
2011English

Pss3 - A Systematic Review and Meta-Analysis of Real-World Evidence Studies of Intravitreal Aflibercept in Wet Age-Related Macular Degeneration

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Self-Management of Age-Related Macular Degeneration and Quality of Life

Archives of Ophthalmology
2002English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy